iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/15118489
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jun;24(3):339-42.
doi: 10.1097/01.jcp.0000125686.20338.c1.

Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women

Robert Taylor Segraves  1 , Anita Clayton, Harry Croft, Abraham Wolf, Jill Warnock
Affiliations
Clinical Trial

Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women

Robert Taylor Segraves et al. J Clin Psychopharmacol. 2004 Jun.

Abstract

Premenopausal women meeting operational criteria for idiopathic, acquired, global hypoactive sexual desire disorder were studied in a randomized, double-blind, placebo-controlled, multiple-site escalating dose 112-day trial of bupropion sustained release. Outcome was measured by investigator-rating and self-administered questionnaires. All measures indicated greater sexual responsiveness in women receiving bupropion. The Changes in Sexual Functioning Questionnaire indicated that bupropion had significant effects on increasing measures of sexual arousal, orgasm completion, and sexual satisfaction.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms